Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
NaV1.1 inhibition can reduce visceral hypersensitivity
Juan Salvatierra, Joel Castro, Andelain Erickson, Qian Li, Joao Braz, John Gilchrist, Luke Grundy, Grigori Y. Rychkov, Annemie Deiteren, Rana Rais, Glenn F. King, Barbara S. Slusher, Allan Basbaum, Pankaj J. Pasricha, Stuart M. Brierley, Frank Bosmans
Juan Salvatierra, Joel Castro, Andelain Erickson, Qian Li, Joao Braz, John Gilchrist, Luke Grundy, Grigori Y. Rychkov, Annemie Deiteren, Rana Rais, Glenn F. King, Barbara S. Slusher, Allan Basbaum, Pankaj J. Pasricha, Stuart M. Brierley, Frank Bosmans
View: Text | PDF
Research Article Gastroenterology Neuroscience

NaV1.1 inhibition can reduce visceral hypersensitivity

  • Text
  • PDF
Abstract

Functional bowel disorder patients can suffer from chronic abdominal pain, likely due to visceral hypersensitivity to mechanical stimuli. As there is only a limited understanding of the basis of chronic visceral hypersensitivity (CVH), drug-based management strategies are ill defined, vary considerably, and include NSAIDs, opioids, and even anticonvulsants. We previously reported that the 1.1 subtype of the voltage-gated sodium (NaV; NaV1.1) channel family regulates the excitability of sensory nerve fibers that transmit a mechanical pain message to the spinal cord. Herein, we investigated whether this channel subtype also underlies the abdominal pain that occurs with CVH. We demonstrate that NaV1.1 is functionally upregulated under CVH conditions and that inhibiting channel function reduces mechanical pain in 3 mechanistically distinct mouse models of chronic pain. In particular, we use a small molecule to show that selective NaV1.1 inhibition (a) decreases sodium currents in colon-innervating dorsal root ganglion neurons, (b) reduces colonic nociceptor mechanical responses, and (c) normalizes the enhanced visceromotor response to distension observed in 2 mouse models of irritable bowel syndrome. These results provide support for a relationship between NaV1.1 and chronic abdominal pain associated with functional bowel disorders.

Authors

Juan Salvatierra, Joel Castro, Andelain Erickson, Qian Li, Joao Braz, John Gilchrist, Luke Grundy, Grigori Y. Rychkov, Annemie Deiteren, Rana Rais, Glenn F. King, Barbara S. Slusher, Allan Basbaum, Pankaj J. Pasricha, Stuart M. Brierley, Frank Bosmans

×

Figure 4

Effect of intracolonic administration of Compound B on VMR in an IBS mouse model of TNBS-induced CVH.

Options: View larger image (or click on image) Download as PowerPoint
Effect of intracolonic administration of Compound B on VMR in an IBS mou...
(A) Representative EMG recordings at increasing colorectal distension pressures (mmHg) in healthy control mice with intracolonically (i.c.) administered vehicle (black), or IBS mice i.c. administered with vehicle (orange) or Compound B 100 μM (blue), 30 minutes before recordings. (B) Upper panel: Group data showing that IBS mice with CVH display increased VMRs (visceromotor reflexes) to CRD (colorectal distension) compared with healthy control mice, particularly at a distension pressure of 60 mmHg (***P < 0.001) and 80 mmHg (*P < 0.05). Lower panel: I.c. Compound B administration significantly reduced the VMR to CRD in IBS mice, normalizing responses to healthy control levels; 60 mmHg (***P < 0.001) and 80 mmHg (*P < 0.05). Significance of differences were analyzed by the Generalized Estimating Equation (GEE), followed by the Least Significant Difference (LSD) post hoc test. HC, healthy control; CVH, chronic visceral hypersensitivity.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts